Glycated haemoglobin (HbA1c) IVD, control

Glycated haemoglobin (HbA1c) IVD controls are laboratory reagents designed to validate the accuracy and reliability of tests that measure HbA1c levels in patient blood samples. These controls help ensure that diabetes management tools—such as point-of-care or lab-based HbA1c assays—provide consistent, trustworthy results for monitoring long-term blood sugar control.

These controls are typically regulated as in vitro diagnostics (IVDs) and are supplied as pre-measured, ready-to-use materials for quality assurance in clinical or research settings. They are not medical devices for direct patient treatment but are essential for maintaining the precision of HbA1c testing systems used globally.